Literature DB >> 8452767

Interplay of T lymphocytes and HLA-DR molecules in rheumatoid arthritis.

J J Goronzy1, C M Weyand.   

Abstract

One of the genetic components of seropositive rheumatoid arthritis has been mapped to a short sequence stretch in the third hypervariable region of the HLA-DRB1 gene. A new concept has emerged, proposing that the shared-sequence motif is functional in determining the clinical patterns of rheumatoid arthritis and the severity of the disease in a codominant mode. Patients with a double dose of the shared sequence tend to have more serious disease manifestations, suggesting a model in which the genetic element is involved in perpetuating the disease. The pathogenetic model in which the shared epitope selectively binds and presents an arthritogenic peptide appears too simplistic to account for these findings. Our understanding of how the shared epitope may contribute to forming the molecular complex of the T-cell receptor, peptide, and HLA-DR molecule is advancing. Molecular analyses of the synovial T-cell infiltrate continue to define the various components involved in recruiting T cells to the site of synovial inflammation. Adhesion molecules, predominantly the endothelial cell ligands vascular adhesion molecule 1 and endothelial leukocyte adhesion molecule 1, attract phenotypically selected T cells with a wide spectrum of specificities. The rheumatoid factor-positive B cells may be important antigen-presenting cells in the joint and may activate T cells with many different specificities. Rheumatoid factor immunoglobulin genes show clear evidence of somatic mutation, indicating a T cell-dependent, antigen-driven process. Thus, multiple factors contribute to the composition of the inflammatory infiltrate and may well modulate the repertoire of T cells recruited to the tissue.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452767     DOI: 10.1097/00002281-199305020-00008

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis.

Authors:  H L Rittner; A Zettl; M C Jendro; P Bartz-Bazzanella; J J Goronzy; C M Weyand
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

2.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 3.  The T cell receptor (TCR) in HLA-B27-restricted T cell responses--an introduction.

Authors:  E Märker-Hermann; R Duchmann; E May; B Ackermann; K H Meyer Zum Büschenfelde
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 5.  Problems and paradigms in joint pathology.

Authors:  D L Gardner
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

6.  Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis.

Authors:  J M Meyer; J Han; R Singh; G Moxley
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

7.  Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.

Authors:  C M Weyand; T G McCarthy; J J Goronzy
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Does genetic anticipation occur in familial rheumatoid arthritis?

Authors:  C Deighton; P Heslop; J McDonagh; D Walker; G Thomson
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

9.  The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway.

Authors:  Song Ling; Zhanguo Li; Olga Borschukova; Liqun Xiao; Paul Pumpens; Joseph Holoshitz
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

Authors:  Steven K Lundy; David A Fox
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.